Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,172 papers from all fields of science
Search
Sign In
Create Free Account
tresperimus
Known as:
(4-((3-aminopropyl)amino)butyl)-2-((6-((aminoiminomethyl)amino)hexyl)amino)-2-oxoethyl carbamic acid ester, trihydrochloride
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Carbamates
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
In vitro metabolism of tresperimus by human vascular semicarbazide-sensitive amine oxidase.
P. Claud
,
Y. Artur
,
R. Laine
Drug Metabolism And Disposition
2002
Corpus ID: 10047624
Tresperimus (Cellimis), a new immunosuppressive agent is mainly eliminated through an extensive nonhepatic metabolism, in which…
Expand
2002
2002
Metabolism of tresperimus by rat aorta semicarbazide‐sensitive amine oxidase (SSAO)
P. Claud
,
Y. Artur
,
J. Guichard
,
R. Laine
Fundamental & Clinical Pharmacology
2002
Corpus ID: 20749183
Tresperimus (Cellimis®), a new immunosuppressive agent, is mainly eliminated in the rat through metabolism, in which the…
Expand
2002
2002
Effect of tresperimus on ex vivo expansion of CD34+CD38(-)-enriched cord blood cells.
S. El Marsafy
,
P. Dutartre
,
E. Gluckman
Haematologia
2002
Corpus ID: 22659718
Tresperimus, an analogue of 15-deoxyspergualine (15-DSG), has been found, in rodents, to induce a potent state of tolerance after…
Expand
2001
2001
Involvement of semicarbazide-sensitive amine oxidase in tresperimus metabolism in human and in rat.
P. Claud
,
P. Padovani
,
J. Guichard
,
Y. Artur
,
R. Laine
Drug Metabolism And Disposition
2001
Corpus ID: 20526162
The metabolism of tresperimus, a new immunosuppressive agent, was investigated in vivo and in vitro in rat and in human. Two…
Expand
Review
2001
Review
2001
Tresperimus: a new agent for transplant tolerance induction
D. Simpson
Expert Opinion on Investigational Drugs
2001
Corpus ID: 11259052
Tresperimus is a novel agent that induces allogeneic transplant tolerance. It is structurally related to deoxyspergualin (DSG…
Expand
Review
2001
Review
2001
New developments in the prophylaxis and treatment of graft versus host disease
D. Simpson
Expert Opinion on Pharmacotherapy
2001
Corpus ID: 38513490
Graft versus host disease (GVHD) remains the major obstacle to successful allogeneic bone marrow transplantation. Cyclosporin…
Expand
2001
2001
Tresperimus (Laboratoires Fournier).
E. Mj
2001
Corpus ID: 88615193
: Tresperimus (LF-08-0299) is an immunosuppressant under development by Laboratoires Fournier for its potential use in organ…
Expand
2001
2001
Effect of tresperimus on in vitro human cord blood CD34+ cell differentiation.
S. El Marsafy
,
P. Dutartre
,
E. Gluckman
Haematologia
2001
Corpus ID: 2826530
Tresperimus, an analogue of 15-deoxyspergualin (15-DSG), is immunosuppressive and prevents lethal graft-versus-host disease…
Expand
2001
2001
Tresperimus (Laboratoires Fournier).
M. J. Elices
Current opinion in investigational drugs
2001
Corpus ID: 44454466
Tresperimus (LF-08-0299) is an immunosuppressant under development by Laboratoires Fournier for its potential use in organ…
Expand
1999
1999
Analysis of in vivo immunosuppressive and in vitro interaction with constitutive heat shock protein 70 activity of LF08-0299 (Tresperimus) and analogues.
S. Komesli
,
C. Dumas
,
P. Dutartre
International Journal of Immunopharmacology
1999
Corpus ID: 40151016
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE